secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001396814-24-000120
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira board rejects director Laura Brege's resignation after majority withhold vote
--------------------------------------------------------------------------------

- Laura Brege received majority withhold votes at 2024 annual meeting; tendered resignation per company policy.
- Independent directors unanimously rejected resignation after considering her qualifications, attendance, and prior support.
- Brege stepped down from HLS Therapeutics board on Aug 7 to address overboarding; remains Pacira director until 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681424000120/0001396814-24-000120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681424000120/pcrx-20240903.htm
  HTML page:      https://secwatch.observer/filing/0001396814-24-000120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer